MARKET

PACB

PACB

PacBio
NASDAQ

Real-time Quotes | Nasdaq Last Sale

32.48
+1.08
+3.44%
After Hours: 32.48 0 0.00% 17:55 06/24 EDT
OPEN
31.60
PREV CLOSE
31.40
HIGH
32.88
LOW
31.57
VOLUME
1.64M
TURNOVER
--
52 WEEK HIGH
53.69
52 WEEK LOW
3.350
MARKET CAP
6.44B
P/E (TTM)
-79.5883
1D
5D
1M
3M
1Y
5Y
PacBio collaborating with genomic medicine institute on genomic sequencing
metamorworks/iStock via Getty Images Pacific Biosciences of California (PACB) is collaborating with the Rady Children's Institute for Genomic Medicine on a study to identify potential disease-causing genetic variants to better treat
Seekingalpha · 1d ago
Pacific Biosciences and Rady Children's Institute for Genomic Medicine Announce its First Research Collaboration for Whole Genome Sequencing
Pacific Biosciences of California, Inc. (NASDAQ:PACB)(“Pacific Biosciences” or “PacBio”), a leading provider of high-quality, long-read sequencing platforms, and Rady Children’s Institute
Benzinga · 1d ago
Pacific Biosciences Grants Equity Incentive Award to New Employee
MENLO PARK, Calif., June 11, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing platforms, today announced that the Compensation Committee ...
GlobeNewswire · 06/11 20:05
Genomics Market to Reach USD 94.66 Billion by 2028; Increasing Genomics' Application & Rising Government Investments to Amplify Market Growth: Says Fortune Business Insights(TM)
The global genomics market size is likely to reach USD 94.66 billion by 2028, registering a CAGR of 19.4% during the forecast period. Genomics abilities to manage, prevent and treat diseases majorly assist in precision medicine development. The use of whol...
GlobeNewswire · 05/20 09:58
Cathie Wood's Ark Loads Up Further On Tesla And Cuts Apple Stake
Cathie Wood-led Ark Investment Management on Tuesday snapped up $27.2 million worth of shares in Tesla Inc (NASDAQ: TSLA) after a two-week gap during which shares of the electric vehicle company have retreated about 15%.
Benzinga · 05/19 04:32
The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 17)
Benzinga · 05/18 11:44
Cathie Wood Cuts Apple Stake Almost Entirely — And Buys More Coinbase
Cathie Wood-led Ark Investment Management on Monday shed nearly all of its stake in Apple Inc (NASDAQ: AAPL) and continued to snap up shares of Coinbase Global Inc (NASDAQ: COIN).
Benzinga · 05/18 05:20
Pacific Biosciences Further Expands Leadership Team with Appointment of Dr. Catherine Ball to Newly Created Position of Senior Vice President of Research
Kathleen Lynch has joined as Head of Global Government Affairs and Communications and Michele Farmer has joined as Chief Accounting OfficerMENLO PARK, Calif., May 17, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB), a leadin...
GlobeNewswire · 05/17 20:05
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of PACB. Analyze the recent business situations of PacBio through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average PACB stock price target is 51.50 with a high estimate of 62.00 and a low estimate of 45.00.
EPS
Institutional Holdings
Institutions: 343
Institutional Holdings: 175.96M
% Owned: 88.70%
Shares Outstanding: 198.37M
TypeInstitutionsShares
Increased
77
14.45M
New
78
6.98M
Decreased
77
23.35M
Sold Out
27
5.49M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
-0.09%
Healthcare Equipment & Supplies
+0.04%
Key Executives
Chairman/Independent Director
John Milligan
President/Chief Executive Officer/Director
Christian Henry
Chief Financial Officer
Susan Kim
Lead Director/Independent Director
Bill Ericson
Chief Operating Officer
Mark Van Oene
Senior Vice President
Catherine Ball
Senior Vice President
Denis Zaccarin
Chief Accounting Officer
Michele Farmer
Other
Peter Fromen
Director
Kathy Ordonez
Independent Director
David Botstein
Independent Director
William Ericson
Independent Director
Randall Livingston
Independent Director
Marshall Mohr
Independent Director
Lucy Shapiro
No Data
  • All
  • Financials
  • Insiders
More
About PACB
Pacific Biosciences of California, Inc. designs, develops and manufactures sequencing systems to help scientists resolve genetically complex problems. The Company is engaged in the development, manufacturing and marketing of an integrated platform for genetic analysis. Its Single Molecule, Real-Time (SMRT) technology enables single molecule, real-time detection of biological processes. It offers The SMRT Cell, Phospholinked nucleotides and The PacBio RS II and Sequel instruments. Its SMRT technology enables the observation of deoxyribonucleic acid (DNA) synthesis as it occurs in real-time by harnessing the natural process of DNA replication, which is actuated by the DNA polymerase. Its phospholinked nucleotides have a fluorescent dye attached to the phosphate chain of the nucleotide rather than to the base. The PacBio RS II and Sequel instruments include optics, automated liquid handling, a touchscreen control interface and computational hardware and software.

Webull offers kinds of Pacific Biosciences of California Inc stock information, including NASDAQ:PACB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PACB stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PACB stock methods without spending real money on the virtual paper trading platform.